
zzso are presented to separate 16 frequently occurring cancer symptoms measured on zzso symptom severity rating scales into mild, moderate, and severe categories that are clinically zzso and significant for use in zzso practice zzso At their initial intervention zzso 588 solid tumor cancer patients undergoing chemotherapy reported severity on a standard zzso rating scale for 16 zzso All reporting a one or higher were asked to rate on an zzso scale how much the symptom zzso with enjoyment of life, relationship with others, general daily activities, and zzso Factor analysis revealed that these items tapped into the same dimension, and the items were summed to form an interference zzso zzso for mild, moderate, and severe categories of symptom severity were defined by comparing the differences in interference scores corresponding to each successive increases in severity for each zzso The zzso differed among zzso zzso fatigue, zzso zzso difficulty remembering, and depression had lower zzso for each category compared to other zzso zzso for each symptom were not related to site or stage of cancer, age, or gender but were associated with a global depression zzso zzso were related to limitations in physical function, suggesting differences in the quality of patients' zzso The resulting zzso zzso severity ratings into clinically significant and useful categories that clinicians can use to assess symptoms in their zzso 

